|
ATP11C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26629817742696E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.4421021588571E-11 |
| Normal-vs-Stage2 |
4.14890000000057E-06 |
| Normal-vs-Stage3 |
1.18720000052974E-07 |
| Normal-vs-Stage4 |
1.42230005550914E-10 |
| Stage1-vs-Stage2 |
9.661800E-01 |
| Stage1-vs-Stage3 |
9.796000E-01 |
| Stage1-vs-Stage4 |
5.786000E-02 |
| Stage2-vs-Stage3 |
9.604600E-01 |
| Stage2-vs-Stage4 |
1.689840E-01 |
| Stage3-vs-Stage4 |
1.335160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81209491856293E-11 |
| Normal-vs-AfricanAmerican |
2.32749999999893E-05 |
| Normal-vs-Asian |
1.90939999999973E-06 |
| Caucasian-vs-AfricanAmerican |
9.689200E-01 |
| Caucasian-vs-Asian |
6.202600E-01 |
| AfricanAmerican-vs-Asian |
7.666000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.75620012660738E-10 |
| Normal-vs-Female |
4.78289630123641E-11 |
| Male-vs-Female |
4.285400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70359999943182E-08 |
| Normal-vs-Age(41-60Yrs) |
5.55666623824891E-13 |
| Normal-vs-Age(61-80Yrs) |
1.37869999861095E-08 |
| Normal-vs-Age(81-100Yrs) |
4.785800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.881600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.382160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.764800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.260600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.034000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.208400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.379000E-01 |
| Classical-VS-Follicular |
4.590400E-02 |
| Classical-VS-Other |
1.489370E-01 |
| Classical-VS-Normal |
1.54850021694131E-10 |
| Tall-VS-Follicular |
9.832200E-02 |
| Tall-VS-Other |
1.481030E-01 |
| Tall-VS-Normal |
1.390940E-04 |
| Follicular-VS-Other |
6.734800E-01 |
| Follicular-VS-Normal |
1.80479997613503E-09 |
| Other-VS-Normal |
4.401500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.39960290421482E-11 |
| Normal-vs-N1 |
2.8325000123175E-09 |
| N0-vs-N1 |
8.457000E-01 |
|
|
